Extract from the Register of European Patents

EP About this file: EP0299877

EP0299877 - Salbutamol tablets with a hydrophilic matrix, and method for their preparation [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  14.01.1993
Database last updated on 28.03.2026
Most recent event   Tooltip14.01.1993No opposition filed within time limitpublished on 03.03.1993 [1993/09]
Applicant(s)For all designated states
PIERRE FABRE MEDICAMENT
45, Place Abel Gance
92100 Boulogne / FR
[N/P]
Former [1991/50]For all designated states
PIERRE FABRE MEDICAMENT
45, Place Abel Gance
F-92100 Boulogne / FR
Former [1989/17]For all designated states
PIERRE FABRE MEDICAMENT
125, Rue de la Faisanderie
F-75116 Paris / FR
Former [1989/03]For all designated states
PIERRE FABRE MEDICAMENT
125 rue de la Faisanderie
F-75116 Paris / FR
Inventor(s)01 / Sournac, Michel
32, rue des Viviers Saix
F-81100 Castres / FR
02 / Bougaret, Joel
36, Bd Maréchal Joffre
F-81100 Castres / FR
[1989/03]
Representative(s)Ahner, Francis, et al
Cabinet Regimbeau
20, rue de Chazelles
75847 Paris Cedex 17 / FR
[N/P]
Former [1989/03]Ahner, Francis, et al
CABINET REGIMBEAU 26, avenue Kléber
F-75116 Paris / FR
Application number, filing date88401846.615.07.1988
[1989/03]
Priority number, dateFR1987001004816.07.1987         Original published format: FR 8710048
[1989/03]
Filing languageFR
Procedural languageFR
PublicationType: A1 Application with search report 
No.:EP0299877
Date:18.01.1989
Language:FR
[1989/03]
Type: B1 Patent specification 
No.:EP0299877
Date:11.03.1992
Language:FR
[1992/11]
Search report(s)(Supplementary) European search report - dispatched on:EP28.11.1988
ClassificationIPC:A61K31/135, A61K9/22
[1989/03]
CPC:
A61K9/2059 (EP,US); A61K31/135 (EP,US); A61K9/2009 (EP,US);
A61K9/2018 (EP,US); A61K9/2054 (EP,US); A61P11/00 (EP);
A61P25/02 (EP) (-)
Designated contracting statesAT,   BE,   CH,   DE,   ES,   FR,   GB,   GR,   IT,   LI,   LU,   NL,   SE [1989/03]
TitleGerman:Salbutamoltabletten mit hydrophiler Matrix und Verfahren zu ihrer Herstellung[1992/11]
English:Salbutamol tablets with a hydrophilic matrix, and method for their preparation[1989/03]
French:Comprimés de type à matrice hydrophile à base de salbutamol et leur procédé de préparation[1989/03]
Former [1989/03]Salbutamoltabletten mit hydrophiler Matix und Verfahren zu ihrer Herstellung
Examination procedure03.04.1989Examination requested  [1989/23]
14.03.1990Despatch of a communication from the examining division (Time limit: M06)
17.09.1990Reply to a communication from the examining division
22.10.1990Despatch of a communication from the examining division (Time limit: M02)
19.11.1990Reply to a communication from the examining division
02.05.1991Despatch of communication of intention to grant (Approval: No)
22.08.1991Despatch of communication of intention to grant (Approval: later approval)
11.09.1991Communication of intention to grant the patent
25.11.1991Fee for grant paid
25.11.1991Fee for publishing/printing paid
Opposition(s)12.12.1992No opposition filed within time limit [1993/09]
Fees paidRenewal fee
18.06.1990Renewal fee patent year 03
17.06.1991Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[Y]   CHEMICAL ABSTRACTS, vol. 107, no. 14, 5 octobre 1987, page 346, rsum no. 121004r, Columbus, Ohio, US; H.L. BHALLA et al.: "An improvised controlled-release tablet of salbutamol sulfate", & INDIAN J. PHARM. SCI. 1987, 49(1), 22-5 [Y]
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.